390 related articles for article (PubMed ID: 30619112)
21.
Schäffler H; Breitrück A
Front Microbiol; 2018; 9():646. PubMed ID: 29692762
[No Abstract] [Full Text] [Related]
22. Active and Secretory IgA-Coated Bacterial Fractions Elucidate Dysbiosis in Clostridium difficile Infection.
Džunková M; Moya A; Vázquez-Castellanos JF; Artacho A; Chen X; Kelly C; D'Auria G
mSphere; 2016; 1(3):. PubMed ID: 27303742
[TBL] [Abstract][Full Text] [Related]
23. The role of gut microbiota in Clostridium difficile infection.
Samarkos M; Mastrogianni E; Kampouropoulou O
Eur J Intern Med; 2018 Apr; 50():28-32. PubMed ID: 29428498
[TBL] [Abstract][Full Text] [Related]
24. Impact of Oral Fidaxomicin Administration on the Intestinal Microbiota and Susceptibility to Clostridium difficile Colonization in Mice.
Ajami NJ; Cope JL; Wong MC; Petrosino JF; Chesnel L
Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29463537
[No Abstract] [Full Text] [Related]
25. Nonsteroidal Anti-inflammatory Drugs Alter the Microbiota and Exacerbate
Maseda D; Zackular JP; Trindade B; Kirk L; Roxas JL; Rogers LM; Washington MK; Du L; Koyama T; Viswanathan VK; Vedantam G; Schloss PD; Crofford LJ; Skaar EP; Aronoff DM
mBio; 2019 Jan; 10(1):. PubMed ID: 30622186
[No Abstract] [Full Text] [Related]
26. Bacterial and Fungal Microbiota Changes Distinguish C. difficile Infection from Other Forms of Diarrhea: Results of a Prospective Inpatient Study.
Sangster W; Hegarty JP; Schieffer KM; Wright JR; Hackman J; Toole DR; Lamendella R; Stewart DB
Front Microbiol; 2016; 7():789. PubMed ID: 27252696
[TBL] [Abstract][Full Text] [Related]
27. Effects of intestinal colonization by Clostridium difficile and Staphylococcus aureus on microbiota diversity in healthy individuals in China.
Dong D; Ni Q; Wang C; Zhang L; Li Z; Jiang C; EnqiangMao ; Peng Y
BMC Infect Dis; 2018 May; 18(1):207. PubMed ID: 29724187
[TBL] [Abstract][Full Text] [Related]
28. A combination of the probiotic and prebiotic product can prevent the germination of Clostridium difficile spores and infection.
Rätsep M; Kõljalg S; Sepp E; Smidt I; Truusalu K; Songisepp E; Stsepetova J; Naaber P; Mikelsaar RH; Mikelsaar M
Anaerobe; 2017 Oct; 47():94-103. PubMed ID: 28465256
[TBL] [Abstract][Full Text] [Related]
29. Proton-Pump Inhibitor Exposure Aggravates Clostridium difficile-Associated Colitis: Evidence From a Mouse Model.
Hung YP; Ko WC; Chou PH; Chen YH; Lin HJ; Liu YH; Tsai HW; Lee JC; Tsai PJ
J Infect Dis; 2015 Aug; 212(4):654-63. PubMed ID: 25805751
[TBL] [Abstract][Full Text] [Related]
30. Bacteroides fragilis Strain ZY-312 Defense against Cronobacter sakazakii-Induced Necrotizing Enterocolitis
Fan H; Chen Z; Lin R; Liu Y; Wu X; Puthiyakunnon S; Wang Y; Zhu B; Zhang Q; Bai Y; Zhi F
mSystems; 2019 Aug; 4(4):. PubMed ID: 31387931
[No Abstract] [Full Text] [Related]
31.
Jenior ML; Leslie JL; Young VB; Schloss PD
mSystems; 2017; 2(4):. PubMed ID: 28761936
[No Abstract] [Full Text] [Related]
32. Clostridium difficile Modulates the Gut Microbiota by Inducing the Production of Indole, an Interkingdom Signaling and Antimicrobial Molecule.
Darkoh C; Plants-Paris K; Bishoff D; DuPont HL
mSystems; 2019; 4(2):. PubMed ID: 30944877
[No Abstract] [Full Text] [Related]
33. Intestinal Microbiota in Elderly Inpatients with
Vakili B; Fateh A; Asadzadeh Aghdaei H; Sotoodehnejadnematalahi F; Siadat SD
Infect Drug Resist; 2020; 13():2723-2731. PubMed ID: 32801806
[TBL] [Abstract][Full Text] [Related]
34. Human Clostridium difficile infection: inhibition of NHE3 and microbiota profile.
Engevik MA; Engevik KA; Yacyshyn MB; Wang J; Hassett DJ; Darien B; Yacyshyn BR; Worrell RT
Am J Physiol Gastrointest Liver Physiol; 2015 Mar; 308(6):G497-509. PubMed ID: 25552580
[TBL] [Abstract][Full Text] [Related]
35. A Novel Microbiome Therapeutic Increases Gut Microbial Diversity and Prevents Recurrent Clostridium difficile Infection.
Khanna S; Pardi DS; Kelly CR; Kraft CS; Dhere T; Henn MR; Lombardo MJ; Vulic M; Ohsumi T; Winkler J; Pindar C; McGovern BH; Pomerantz RJ; Aunins JG; Cook DN; Hohmann EL
J Infect Dis; 2016 Jul; 214(2):173-81. PubMed ID: 26908752
[TBL] [Abstract][Full Text] [Related]
36. A High-Fat/High-Protein, Atkins-Type Diet Exacerbates
Mefferd CC; Bhute SS; Phan JR; Villarama JV; Do DM; Alarcia S; Abel-Santos E; Hedlund BP
mSystems; 2020 Feb; 5(1):. PubMed ID: 32047064
[No Abstract] [Full Text] [Related]
37. Colonization Resistance of the Gut Microbiota against Clostridium difficile.
Pérez-Cobas AE; Moya A; Gosalbes MJ; Latorre A
Antibiotics (Basel); 2015 Aug; 4(3):337-57. PubMed ID: 27025628
[TBL] [Abstract][Full Text] [Related]
38. A Small Molecule-Screening Pipeline to Evaluate the Therapeutic Potential of 2-Aminoimidazole Molecules Against
Thanissery R; Zeng D; Doyle RG; Theriot CM
Front Microbiol; 2018; 9():1206. PubMed ID: 29928268
[TBL] [Abstract][Full Text] [Related]
39. Antimicrobial Use, Human Gut Microbiota and Clostridium difficile Colonization and Infection.
Vincent C; Manges AR
Antibiotics (Basel); 2015 Jul; 4(3):230-53. PubMed ID: 27025623
[TBL] [Abstract][Full Text] [Related]
40. The role of zinc and nutritional immunity in Clostridium difficile infection.
Zackular JP; Skaar EP
Gut Microbes; 2018; 9(5):469-476. PubMed ID: 29533126
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
